Inactive Instrument

News Capnia Inc Nasdaq

Equities

US14066L1052

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 04	Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	MT
Mar. 18	North American Morning Briefing : Investors -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - April 19, 2024	Apr. 22	AQ
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Apr. 19	AQ
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	Apr. 04	MT
North American Morning Briefing : Investors -2-	Mar. 18	DJ
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 08	AQ
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	Mar. 06	AQ
Soleno Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Soleno Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Soleno Therapeutics : March 2024 Corporate Presentation	Mar. 04	PU
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 22	AQ
Piper Sandler Starts Soleno Therapeutics With Overweight Rating, $93 Price Target	Feb. 05	MT
Soleno Therapeutics to Present at Upcoming February Investor Conferences	Feb. 01	AQ
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 29	AQ
Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer	Jan. 24	MT
Soleno Therapeutics Strengthens Leadership Team with Key Appointments	Jan. 24	AQ
Soleno Therapeutics Strengthens Leadership Team with Key Appointments	Jan. 24	CI
Stifel Starts Soleno Therapeutics With Buy Rating, $63 Price Target	Jan. 23	MT
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 05	AQ
Soleno Therapeutics Files Mixed Shelf	Jan. 03	MT
Oppenheimer Lifts Price Target on Soleno Therapeutics to $47 From $44, Maintains Outperform Rating	Jan. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Capnia Inc Nasdaq

Equities

US14066L1052

Summary

Filters